141 related articles for article (PubMed ID: 20508949)
1. Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.
Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
J Cancer Res Clin Oncol; 2011 Mar; 137(3):551-5. PubMed ID: 20508949
[TBL] [Abstract][Full Text] [Related]
2. Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
González LO; González-Reyes S; Junquera S; Marín L; González L; Del Casar JM; González JM; Vizoso F
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1313-21. PubMed ID: 20127359
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.
Del Casar JM; González LO; Alvarez E; Junquera S; Marín L; González L; Bongera M; Vázquez J; Vizoso FJ
Breast Cancer Res Treat; 2009 Jul; 116(1):39-52. PubMed ID: 19241156
[TBL] [Abstract][Full Text] [Related]
5. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
[TBL] [Abstract][Full Text] [Related]
6. Study of matrix metalloproteinases and their inhibitors in prostate cancer.
Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
Br J Cancer; 2010 Mar; 102(5):922-9. PubMed ID: 20160732
[TBL] [Abstract][Full Text] [Related]
7. Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samples.
Fernandez-Gomez J; Escaf S; Gonzalez LO; Suarez A; Gonzalez-Reyes S; González J; Miranda O; Vizoso F
Scand J Urol Nephrol; 2011 Apr; 45(3):171-6. PubMed ID: 21244194
[TBL] [Abstract][Full Text] [Related]
8. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.
Lichtinghagen R; Musholt PB; Lein M; Römer A; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Jung K
Eur Urol; 2002 Oct; 42(4):398-406. PubMed ID: 12361907
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
11. Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.
Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
World J Urol; 2011 Oct; 29(5):657-63. PubMed ID: 20886218
[TBL] [Abstract][Full Text] [Related]
12. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
[TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
Nagel H; Laskawi R; Wahlers A; Hemmerlein B
Histopathology; 2004 Mar; 44(3):222-31. PubMed ID: 14987225
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Tunuguntla R; Ripley D; Sang QX; Chegini N
Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
17. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism.
Azuma H; Inamoto T; Sakamoto T; Kiyama S; Ubai T; Shinohara Y; Maemura K; Tsuji M; Segawa N; Masuda H; Takahara K; Katsuoka Y; Watanabe M
Cancer Res; 2003 Dec; 63(23):8090-6. PubMed ID: 14678958
[TBL] [Abstract][Full Text] [Related]
18. Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
Del Casar JM; González-Reyes S; González LO; González JM; Junquera S; Bongera M; García MF; Andicoechea A; Serra C; Vizoso FJ
J Cancer Res Clin Oncol; 2010 Jun; 136(6):811-9. PubMed ID: 19916023
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Kumamoto H; Yamauchi K; Yoshida M; Ooya K
J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
Brehmer B; Biesterfeld S; Jakse G
Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
